Article 09 Jul 2024 FDA Takes Next Step In Advancing Diversity In Clinical Studies United States Healthcare
Article 03 Jul 2024 Non-Binding Guidance: FDA Regulatory & Enforcement Risks Relevant To Academic Medical Centers, Health Systems And Research Institutions (Podcast) United States Healthcare
Article 11 Mar 2024 New Executive Order Would Restrict Transfer Of Certain Bulk Sensitive Personal Data And United States Government-Related Data To China And Other Countries Of Concern Worldwide Privacy
Article 23 Feb 2024 Inching Toward Harmonization: FDA Finalizes Rule On IRB Waiver Of Informed Consent For Minimal Risk Studies United States Healthcare
Article 29 Aug 2023 FDA Finalizes Guidance On Informed Consent For Clinical Investigations United States Healthcare
Article 08 Dec 2021 HHS Reverses Course On LDTs: COVID-19 LDTs Again Require FDA Premarket Review United States Healthcare
Article 16 Feb 2021 New European Data Protection Board (EDPB) Guidance Highlights – But Leaves Unresolved – Several GDPR Compliance Issues Facing Clinical Researchers European Union Privacy
Article 05 Nov 2020 New HHS Advisory Opinions Support Broad Application Of PREP Act Immunity For COVID-19 Response United States Healthcare
Article 26 May 2020 Accessing New Research Funding Opportunities During And After COVID-19 United States Coronavirus
Article 11 May 2020 Phasing-In: Use Of COVID-19 Testing As A "Return To Work" Strategy United States Coronavirus